Common Stock, Shares, Outstanding of CytomX Therapeutics, Inc. from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CytomX Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • CytomX Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2024 was 80,099,889, a 19% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

CytomX Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 80,099,889 +12,789,051 +19% 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q4 2023 67,310,838 +1,082,792 +1.6% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 66,228,046 +835,288 +1.3% 31 Dec 2022 10-K 11 Mar 2024 2023 FY
Q3 2022 65,950,242 +701,126 +1.1% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 65,756,492 +599,489 +0.92% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 65,398,355 +395,458 +0.61% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 65,392,758 +17,140,939 +36% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 65,249,116 +19,025,714 +41% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 65,157,003 +18,966,933 +41% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 65,002,897 +19,084,281 +42% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 48,251,819 +2,728,731 +6% 31 Dec 2020 10-K/A 27 Mar 2023 2021 FY
Q3 2020 46,223,402 +796,934 +1.8% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 46,190,070 +786,232 +1.7% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 45,918,616 +760,964 +1.7% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 45,523,088 +439,879 +0.98% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 45,426,468 +429,189 +0.95% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 45,403,838 +6,392,059 +16% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 45,157,652 +6,253,953 +16% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 45,083,209 +6,604,649 +17% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 44,997,279 +7,901,817 +21% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 39,011,779 +2,172,437 +5.9% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 38,903,699 +2,184,759 +6% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 38,478,560 +1,988,391 +5.4% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 37,095,462 +702,641 +1.9% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 36,839,342 +651,997 +1.8% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 36,718,940 +633,131 +1.8% 31 Mar 2017 10-Q 05 May 2017 2017 Q1
Q4 2016 36,490,169 +456,960 +1.3% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q3 2016 36,392,821 +35,298,172 +3225% 30 Sep 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 36,187,345 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 36,085,809 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 36,033,209 +35,036,689 +3516% 31 Dec 2015 10-Q 03 Nov 2016 2016 Q3
Q3 2015 1,094,649 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q4 2014 996,520 31 Dec 2014 10-K 07 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.